Characterization of the endocannabinoid system, CB 1 receptor signalling and desensitization in human myometrium

British Journal of Pharmacology

Volumn 164, Issue 5, 2011, Pages 1479-1494

  Brighton, Paul J ^a   Marczylo, Timothy H ^a   Rana, Shashi ^a   Konje, Justin C ^a   Willets, Jonathon M ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

anandamide; arrestin; CB1 receptor; endocannabinoid; ERK

Indexed keywords

ADENYLATE CYCLASE; ANANDAMIDE; ARRESTIN 3; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CYCLIC AMP; FATTY ACID AMIDASE; METHANANDAMIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE D; RETINA S ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SPECIFICITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; MOLECULAR STABILITY; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; SECOND MESSENGER;

ADULT; ARACHIDONIC ACIDS; ARRESTINS; BINDING, COMPETITIVE; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELLS, CULTURED; ENDOCANNABINOIDS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; MIDDLE AGED; MYOMETRIUM; POLYUNSATURATED ALKAMIDES; PROTEIN BINDING; RADIOLIGAND ASSAY; RECEPTOR, CANNABINOID, CB1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 80054011406     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01425.x     Document Type: Article

References (43)

1. Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, Pertwee RG, et al,. (1994). (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem 37: 1889-1893. (Pubitemid 24219781)
2. Ahn S, Nelson CD, Garrison TR, Miller WE, Lefkowitz RJ, (2003). Desensitization, internalization, and signaling functions of β-arrestins demonstrated by RNA interference. Proc Natl Acad Sci USA 100: 1740-1744. (Pubitemid 36254518)
3. Alexander SPH, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1): S1-S254.
4. Bambang KN, Karasu T, Gebeh A, Taylor AH, Marczylo TH, Lam P, et al,. (2010). From fertilization to implantation in mammalian pregnancy-modulation of early human reproduction by the endocannabinoid system. Pharmaceuticals 3: 2910-2929.
5. 1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem J 351: 817-824.
6. Brenninkmeijer CB, Price SA, Lopez Bernal A, Phaneuf S, (1999). Expression of G-protein-coupled receptor kinases in pregnant term and non-pregnant human myometrium. J Endocrinol 162: 401-408. (Pubitemid 29447433)
7. Brighton PJ, McDonald J, Taylor AH, Challiss RA, Lambert DG, Konje JC, et al,. (2009). Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells. Mol Endocrinol 23: 1415-1427.
8. Brown BL, Albano JD, Ekins RP, Sgherzi AM, (1971). A simple and sensitive saturation assay method for the measurement of adenosine 3′:5′- cyclic monophosphate. Biochem J 121: 561-562.
9. 50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.
10. Chomczynski P, Mackey K, (1995). Substitution of chloroform by bromo-chloropropane in the single-step method of RNA isolation. Anal Biochem 225: 163-164.
11. Daigle TL, Kwok ML, Mackie K, (2008). Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism. J Neurochem 106: 70-82. (Pubitemid 351840192)
12. Dennedy MC, Friel AM, Houlihan DD, Broderick VM, Smith T, Morrison JJ, (2004). Cannabinoids and the human uterus during pregnancy. Am J Obstet Gynecol 190: 2-9; discussion 3A. (Pubitemid 38156315)
13. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK, (2007). β-arrestins and cell signaling. Annu Rev Physiol 69: 483-510.
14. El-Talatini MR, Taylor AH, Konje JC, (2009a). Fluctuation in anandamide levels from ovulation to early pregnancy in in-vitro fertilization-embryo transfer women, and its hormonal regulation. Hum Reprod 24: 1989-1998.
15. El-Talatini MR, Taylor AH, Konje JC, (2009b). The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle. Fertil Steril 93: 1986-1996.
16. Grimsey NL, Goodfellow CE, Scotter EL, Dowie MJ, Glass M, Graham ES, (2008). Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal! J Neurosci Methods 171: 78-86.
17. Habayeb OM, Taylor AH, Evans MD, Cooke MS, Taylor DJ, Bell SC, et al,. (2004). Plasma levels of the endocannabinoid anandamide in women-a potential role in pregnancy maintenance and labor? J Clin Endocrinol Metab 89: 5482-5487. (Pubitemid 39518429)
18. Habayeb OM, Taylor AH, Finney M, Evans MD, Konje JC, (2008). Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. JAMA 299: 1135-1136. (Pubitemid 351398442)
19. Jin W, Brown S, Roche JP, Hsieh C, Celver JP, Kovoor A, et al,. (1999). Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J Neurosci 19: 3773-3780. (Pubitemid 29222253)
20. 1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey. Br J Pharmacol 163: 1214-1222.
21. Lam PM, Marczylo TH, El-Talatini M, Finney M, Nallendran V, Taylor AH, et al,. (2008). Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma. Anal Biochem 380: 195-201.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
23. Maccarrone M, (2009). Endocannabinoids: friends and foes of reproduction. Prog Lipid Res 48: 344-354.
24. Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agro A, (2000). Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet 355: 1326-1329. (Pubitemid 30199005)
25. Makriyannis A, Tian X, Guo J, (2005). How lipophilic cannabinergic ligands reach their receptor sites. Prostaglandins Other Lipid Mediat 77: 210-218. (Pubitemid 41133429)
26. Molnar M, Rigo J Jr, Romero R, Hertelendy F, (1999). Oxytocin activates mitogen-activated protein kinase and up-regulates cyclooxygenase-2 and prostaglandin production in human myometrial cells. Am J Obstet Gynecol 181: 42-49. (Pubitemid 29343329)
27. O'Sullivan SE, (2007). Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol 152: 576-582. (Pubitemid 350034977)
28. Oddi S, Fezza F, Catanzaro G, De Simone C, Pucci M, Piomelli D, et al,. (2010). Pitfalls and solutions in assaying anandamide transport in cells. J Lipid Res 51: 2435-2444.
29. Paria BC, Das SK, Dey SK, (1995). The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proc Natl Acad Sci USA 92: 9460-9464.
30. Park B, Gibbons HM, Mitchell MD, Glass M, (2003). Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. Placenta 24: 990-995.
31. Ross RA, Brockie HC, Stevenson LA, Murphy VL, Templeton F, Makriyannis A, et al,. (1999). Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. Br J Pharmacol 126: 665-672. (Pubitemid 29087845)
32. Sale S, Fong IL, de Giovanni C, Landuzzi L, Brown K, Steward WP, et al,. (2009). APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the Apc(Min) mouse model in vivo. Eur J Cancer 45: 2731-2735.
33. Taylor AH, Ang C, Bell SC, Konje JC, (2007). The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy. Hum Reprod Update 13: 501-513. (Pubitemid 47299855)
34. Taylor AH, Amoako AA, Bambang K, Karasu T, Gebeh A, Lam PM, et al,. (2010). Endocannabinoids and pregnancy. Clin Chim Acta 411: 921-930.
35. Trabucco E, Acone G, Marenna A, Pierantoni R, Cacciola G, Chioccarelli T, et al,. (2009). Endocannabinoid system in first trimester placenta: low FAAH and high CB1 expression characterize spontaneous miscarriage. Placenta 30: 516-522.
36. Vandevoorde S, Lambert DM, (2007). The multiple pathways of endocannabinoid metabolism: a zoom out. Chem Biodivers 4: 1858-1881. (Pubitemid 47381194)
37. Wang H, Xie H, Dey SK, (2006a). Endocannabinoid signaling directs periimplantation events. AAPS J 8: E425-E432. (Pubitemid 43958374)
38. Wang Q, Lu R, Zhao J, Limbird LE, (2006b). Arrestin serves as a molecular switch, linking endogenous alpha2-adrenergic receptor to SRC-dependent, but not SRC-independent, ERK activation. J Biol Chem 281: 25948-25955. (Pubitemid 44401800)
39. Wenger T, Fragkakis G, Giannikou P, Probonas K, Yiannikakis N, (1997). Effects of anandamide on gestation in pregnant rats. Life Sci 60: 2361-2371. (Pubitemid 27235111)
40. Willets J, Kelly E, (2001). Desensitization of endogenously expressed Î-opioid receptors: no evidence for involvement of G protein-coupled receptor kinase 2. Eur J Pharmacol 431: 133-141. (Pubitemid 33132119)
41. Willets JM, Challiss RA, Nahorski SR, (2003). Non-visual GRKs: are we seeing the whole picture? Trends Pharmacol Sci 24: 626-633. (Pubitemid 37494784)
42. 1 histamine receptor signaling by G protein-coupled receptor kinase 2 in uterine smooth muscle cells. Mol Endocrinol 22: 1893-1907.
43. Wu DF, Yang LQ, Goschke A, Stumm R, Brandenburg LO, Liang YJ, et al,. (2008). Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors. J Neurochem 104: 1132-1143. (Pubitemid 351143650)